MRNA
Moderna Inc
NASDAQ: MRNA · HEALTHCARE · BIOTECHNOLOGY
$45.72
-3.01% today
Updated 2026-04-29
Market cap
$18.13B
P/E ratio
—
P/S ratio
9.33x
EPS (TTM)
$-7.26
Dividend yield
—
52W range
$22 – $60
Volume
7.5M
Moderna Inc (MRNA) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $500000.00 | $0.00 | $108.40M | $205.82M | $122.51M | $48.04M | $274.49M | $17.74B | $18.88B | $6.85B | $3.20B | $1.94B |
| Revenue growth (YoY) | — | -100.0% | — | +89.9% | -40.5% | -60.8% | +471.4% | +6361.4% | +6.4% | -63.7% | -53.3% | -39.2% |
| Cost of revenue | $0.00 | $0.00 | $15.11M | $20.54M | $454.08M | $496.31M | $7.93M | $2.62B | $5.42B | $4.69B | $1.46B | $868.00M |
| Gross profit | $500000.00 | $0.00 | $93.28M | $185.29M | $-331.57M | $48.04M | $266.56M | $15.12B | $13.46B | $2.15B | $1.74B | $1.08B |
| Gross margin | 100.0% | — | 86.1% | 90.0% | -270.6% | 100.0% | 97.1% | 85.2% | 71.3% | 31.5% | 54.2% | 55.3% |
| R&D | $686000.00 | $322317.00 | $274.72M | $410.46M | $454.08M | $496.31M | $1.37B | $1.99B | $3.29B | $4.84B | $4.54B | $3.13B |
| SG&A | $3.33M | $785261.00 | $57.45M | $64.72M | $94.25M | $109.62M | $188.27M | $567.00M | $1.01B | $1.34B | $1.03B | $1.02B |
| Operating income | $-3.52M | $-1.11M | $-223.77M | $-269.36M | $-413.27M | $-545.72M | $-763.14M | $13.30B | $9.42B | $-4.24B | $-3.94B | $-3.07B |
| Operating margin | -704.0% | — | -206.4% | -130.9% | -337.3% | -1136.1% | -278.0% | 75.0% | 49.9% | -61.9% | -123.3% | -158.1% |
| EBITDA | — | — | $-208.66M | $-235.33M | $-388.40M | $-514.70M | $-731.89M | $13.53B | $9.77B | $-3.28B | $-3.39B | $-2.55B |
| EBITDA margin | 0.0% | — | -192.5% | -114.3% | -317.0% | -1071.5% | -266.6% | 76.3% | 51.8% | -47.9% | -106.1% | -131.3% |
| EBIT | $-5.48M | $-1.11M | $-223.77M | $-255.86M | $-413.27M | $-545.72M | $-763.14M | $13.30B | $9.42B | $-3.90B | $-3.58B | $-2.77B |
| Interest expense | $0.00 | $0.00 | $0.00 | $132000.00 | $3.10M | $6.61M | $9.89M | $18.00M | $29.00M | $38.00M | $24.00M | $10.00M |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-6.48M | $-1.11M | $-216.21M | $-255.92M | $-384.73M | $-514.02M | $-747.06M | $12.20B | $8.36B | $-4.71B | $-3.56B | $-2.82B |
| Net income growth (YoY) | — | +82.9% | -19403.7% | -18.4% | -50.3% | -33.6% | -45.3% | +1733.3% | -31.5% | -156.4% | +24.5% | +20.8% |
| Profit margin | -1295.4% | — | -199.5% | -124.3% | -314.0% | -1070.1% | -272.2% | 68.8% | 44.3% | -68.8% | -111.3% | -145.2% |